Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes (Q43812550)

27 November 2017

title

Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes (English)

1 reference

27 November 2017

Zhengzhong Wang

1

1 reference

27 November 2017

Hongyan Dai

2

1 reference

27 November 2017

Mingqing Xing

3

1 reference

27 November 2017

Zhongxiang Yu

4

1 reference

27 November 2017

Xianru Lin

5

1 reference

27 November 2017

Shoudong Wang

6

1 reference

27 November 2017

Junyi Zhang

7

1 reference

27 November 2017

Fangjie Hou

8

1 reference

27 November 2017

Ying Ma

9

1 reference

27 November 2017

Yongqiang Ren

10

1 reference

27 November 2017

Kai Tan

11

1 reference

27 November 2017

Yanping Wang

12

1 reference

27 November 2017

Zhiming Ge

13

1 reference

27 November 2017

publication date

29 January 2013

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

27 November 2017

published in

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

327-333

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Frequency and long-term impact of myonecrosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Influence of statin use on endothelial function: from bench to clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Modulation of human T cells signaling transduction by lovastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Inflammatory response to coronary stent implantation in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

Interleukins in atherosclerosis: molecular pathways and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412474346

21 January 2018

Identifiers

DOI

10.1177/1074248412474346

1 reference

27 November 2017

1 reference